Centrus Energy Delivers Steady Revenue Growth: Is It Sustainable?

Centrus Energy reported robust Q1 2025 results, with total revenues up 67% year-over-year to $73 million, largely propelled by a 117% surge in its LEU segment from increased SWU prices and volumes. The company's Technical Solutions segment also grew 8%, benefiting from an extended HALEU contract, where Centrus holds a significant first-mover advantage in a market projected to expand to $6.2 billion by 2035. Despite a substantial $3.8 billion revenue backlog and a 225.1% year-to-date share price increase, the company trades at a premium 8.21x forward price/sales multiple and faces analyst forecasts for declining EPS in 2025 and 2026, contributing to a Zacks Rank #4 (Sell).

Analysis

Centrus Energy (LEU) reported exceptional top-line growth in Q1 2025, with total revenues surging 67% year-over-year to $73 million. This performance was primarily driven by its Low-Enriched Uranium (LEU) segment, where revenue skyrocketed 117% to $51.3 million, supported by a 46% increase in SWU prices and a 49% rise in volumes. The Technical Solutions segment also contributed positively, with an 8% revenue increase due to its High-Assay Low-Enriched Uranium (HALEU) contract with the U.S. Department of Energy, which has been extended through mid-2026. The company's long-term outlook is underpinned by a substantial $3.8 billion revenue backlog and a significant first-mover advantage as the only licensed HALEU producer in a market projected to grow to $6.2 billion by 2035. However, this positive operational momentum is contrasted by significant valuation and profitability concerns. The stock has appreciated 225.1% year-to-date, pushing its forward price/sales multiple to 8.21x, a steep premium to the industry's 2.81x. More critically, consensus earnings estimates project a 22.8% EPS decline in 2025 followed by an 18.48% decline in 2026, culminating in a Zacks Rank of #4 (Sell). This disconnect between revenue growth and future earnings forecasts presents a challenging investment picture.

Key Decisions for Investors

• Investors should weigh the company's strong revenue growth and unique strategic position in the HALEU market against the significant red flags of a premium valuation and sharply declining earnings per share forecasts for 2025 and 2026.
• Given the 225.1% year-to-date share price increase and a forward P/S multiple nearly three times the industry average, current holders may consider trimming positions to crystallize gains.
• Potential new investors should exercise caution, as the current share price appears to have priced in significant future growth that may not be supported by near-term profitability, as indicated by negative analyst revisions and a 'Sell' rating.
• Monitor future announcements related to the HALEU contract and the conversion of the $3.8 billion backlog into profitable revenue streams, as this will be critical to justifying the stock's current valuation.